Search Results

181 documents have been found for your search on: local coverage determination
 

Type
Title
78%
Policy MA05.012a
Orthopedic Footwear
78%
Policy MA05.050a
Eye Prostheses and Scleral Cover Shell
77%
Policy MA05.014a
Ostomy Supplies
76%
Policy MA07.047f
Pain Management of Peripheral Nerves by Injection
76%
Policy MA05.011a
Seat Lift Mechanisms
76%
Policy MA07.011a
Topical Oxygenation
76%
Policy MA05.052b
Canes and Crutches
76%
Policy MA05.037
Walkers
76%
Policy MA05.029b
Heating Pads and Heat Lamps
76%
Policy MA07.018a
Anorectal Manometry, Electromyography (EMG) of Anorectal or Urethral Sphincters; Biofeedback Training for Perineal Muscles and Anorectal or Urethral Sphincters
75%
Policy MA05.042a
Pulse Oximeters in the Home Setting
75%
Policy MA05.045a
Compression Garments
74%
Policy MA07.058g
Sleep Disorder Testing and Positive Airway Pressure Therapy Services and Supplies
74%
Policy MA05.036b
Commode Chairs
74%
Policy MA05.035b
Cold Therapy Devices
74%
Policy MA00.004a
Routine Costs of Clinical Trials and Coverage of Investigational Devices A and B
73%
Policy MA09.002j
High-Technology Radiology Services
73%
Notification MA09.002k
High-Technology Radiology Services
73%
Policy MA05.025c
Pressure-Reducing Support Surfaces
73%
Policy MA08.003d
Enteral Nutritional Therapy
73%
Policy MA05.031a
Patient Lifts
73%
Policy MA06.007c
Loss-of-Heterozygosity-Based Topographic Genotyping with PathFinderTG®
73%
Policy MA05.026a
Manual Wheelchairs
73%
Policy MA11.036c
Surgical Treatment of Nails
73%
Policy MA05.018a
Osteogenic Stimulators (i.e., Electrical Bone Growth Stimulation and Low-Intensity Ultrasound Accelerated Fracture Healing System)
73%
Policy MA05.053f
Implantable and External Infusion Pumps
73%
Policy MA07.001a
Hyperbaric Oxygen Therapy
73%
Policy MA03.015
Electrocardiogram (ECG/EKG) Reported with Single Photon Emission Computed Tomography (SPECT) for Myocardial Perfusion Imaging (MPI)
72%
Policy MA08.009h
Immune Globulin: Intravenous (IVIG), Subcutaneous (SCIG)
72%
Policy MA05.017b
Home Oxygen Therapy
72%
Policy MA11.113b
Percutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound
72%
Policy MA05.008a
Negative Pressure Wound Therapy (NPWT) Systems
72%
Policy MA05.004c
Pneumatic Compression Therapy Devices
72%
Policy MA11.024d
Percutaneous Vertebroplasty and Percutaneous Vertebral Augmentation
72%
Policy Att. MA05.044f
Attachment B (MA05.044f Durable Medical Equipment (DME))
Items that Do Not Meet the Definition of Durable Medical Equipment (DME) or Excluded from Coverage by Medicare
72%
Policy MA07.051e
Intraoperative Neurophysiological Testing
71%
Policy MA08.008c
Total Parenteral Nutrition (TPN) / Intradialytic Parenteral Nutrition (IDPN) / Intraperitoneal Nutrition (IPN)
71%
Policy MA11.016a
Prostate Mapping Biopsy
71%
Policy MA05.024c
Lower Limb Prostheses
71%
Policy MA05.054d
Urological Supplies
71%
Policy MA05.033a
External Breast Prosthesis
71%
Policy MA11.011c
Artificial Hearts and Ventricular Assist Devices (VADs)
71%
Policy MA05.015c
Home Blood Glucose Monitors and Supplies
70%
Notification MA11.023i
Hyaluronan Acid Therapies for Osteoarthritis of the Knee
70%
Policy MA05.006d
Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies
70%
Policy MA11.008c
Refractive Keratoplasty
70%
Policy MA00.040a
Facility Reporting of Observation Services
70%
Policy MA09.004a
Echocardiography Contrast Agents
70%
Policy MA11.076c
Removal of Breast Implants
70%
Policy MA06.030
Circulating Tumor Cell (CTC) Assay
69%
Policy MA05.005c
Automatic External Cardioverter Defibrillators (Wearable and Nonwearable)
69%
Policy MA05.046d
Wheelchair Options and Accessories
69%
Policy MA05.009
Cervical Traction Devices for In-home Use
69%
Policy MA12.009
Cosmetic Procedures
69%
Policy MA05.002c
Hospital Beds and Accessories
69%
Policy MA01.004a
Continuous Local Delivery of Anesthesia to Operative Sites Using an Elastomeric Infusion Pump
69%
Policy MA03.016
Insertion or Application of Urinary Catheters and the Associated Supplies Provided in the Office Setting
68%
Policy MA10.002b
Cardiac Rehabilitation (CR) and Intensive Cardiac Rehabilitation (ICR) Programs
68%
Policy MA08.012b
Off-label Coverage for Prescription Drugs and/or Biologics
68%
Policy MA08.058c
Blinatumomab (Blincyto®)
68%
Policy MA05.003c
Speech and Non-Speech Generating Devices
68%
Policy MA11.023h
Hyaluronan Acid Therapies for Osteoarthritis of the Knee
68%
Policy MA11.051a
Treatment of Obesity and Bariatric Surgery for Treatment of Morbid Obesity
68%
Policy MA11.056e
Percutaneous Transluminal Angioplasty (PTA) Concurrent with or without Stenting and Extracranial- Intracranial (EC-IC) Arterial Bypass Surgery
68%
Policy MA07.022b
Wireless Capsule Endoscopy
67%
Policy Att. MA06.017q
Attachment E (MA06.017q Molecular Diagnostics)
Services that are coverable via Coverage with Evidence Development (CED), registry-based approach, or other properly-designed designs
67%
Policy Att. MA06.008b
Attachment B (MA06.008b Pharmacogenetic Testing to Determine Drug Sensitivity)
Pharmacogenomic testing (CYP2C9 or VKORC1 alleles) for predicting warfarin response
67%
Policy MA00.038a
Marijuana for Medical Use
67%
Policy MA07.007f
Pulmonary Function Tests
67%
Policy MA05.034
Tracheostomy Care Supplies
67%
Policy MA05.020f
Therapeutic Shoes
67%
Policy MA11.067d
Labiaplasty
67%
Policy MA11.017e
Trigger Point Injections
67%
Policy MA05.023a
Wheelchair Cushions and Seating
67%
Policy MA05.030c
Spinal Orthoses
67%
Policy MA05.058a
Neuromuscular Electrical Stimulators (NMES) and Functional Electrical Stimulators (FES)
67%
Policy MA08.083a
Gonadotropin-Releasing Hormone Agonist (Eligard®, Lupron Depot®)
67%
Policy MA05.061
Home Use of Interferential and Sequential Stimulation Devices
66%
Policy MA11.099a
Septoplasty, Rhinoplasty, and Septorhinoplasty
66%
Policy MA11.018c
Mohs' Micrographic Surgery (MMS)
66%
Policy MA08.053a
Personalized Vaccines (e.g., Provenge®)
66%
Policy MA05.010d
Ankle-Foot/Knee-Ankle-Foot Orthoses
66%
Policy MA11.110
Surgery for Gynecomastia
66%
Policy MA11.073c
Panniculectomy, Abdominoplasty, Abdominal Lipectomy, and Other Excisions of Redundant Skin
66%
Policy MA05.032
Power Wheelchairs (PWCs), Power-Operated Vehicles (POVs), and Push-Rim Activated Power-Assist Devices
66%
Policy MA05.001c
High-Frequency Chest Wall Oscillation Devices
66%
Policy MA07.027b
Autonomic Nervous System Testing
66%
Policy MA10.007b
Speech Therapy
66%
Policy MA02.001a
Hospice Care
65%
Policy MA06.004a
In Vivo Allergy Sensitivity Testing
65%
Policy MA05.013c
Knee Orthoses
65%
Policy MA05.063c
Repair or Replacement of an External Prosthetic Device
64%
Policy MA11.007
Islet Cell Transplantation
64%
Policy MA08.004p
Coagulation Factors
64%
Policy MA08.007o
Medicare Part B vs. Part D Crossover Drugs
64%
Policy MA07.023e
Upper Gastrointestinal Endoscopy (Diagnostic and Therapeutic)
64%
Policy MA00.047b
Musculoskeletal Services
64%
Policy MA08.077d
Talimogene laherparepvec (Imlygic™)
64%
Policy MA11.052b
Radiofrequency Ablation and Cryosurgical Ablation of Lung Tumors
63%
Policy MA08.086d
Nusinersen (Spinraza®)
63%
Policy MA08.102a
Mogamulizumab-kpkc (Poteligeo®)
63%
Policy MA11.014e
Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails
63%
Policy MA07.013d
Electrical Stimulation and Electromagnetic Stimulation for the Treatment of Wounds
63%
Policy MA08.026e
Treatments for Complex Regional Pain Syndrome (CRPS)
63%
Policy MA08.043d
Pralatrexate (Folotyn®) for Injection
63%
Policy MA08.055e
Histone Deacetylase Inhibitors for Peripheral T-cell Lymphoma (e.g., Istodax®, Beleodaq®)
63%
Policy MA11.026d
Epidural, Paravertebral Facet, and Sacroiliac Joint Injections for Spinal Pain Management
63%
Policy MA11.047c
Blepharoplasty, Repair of Blepharoptosis, Repair of Brow Ptosis, and Canthoplasty/Canthopexy
63%
Policy MA07.035c
Transcranial Magnetic Stimulation (TMS)
63%
Policy MA12.002a
Nonemergency Ambulance Transport
63%
Policy MA07.029b
Refractive Lenses
62%
Policy MA11.015i
Wound Care: Skin Substitutes for the Treatment of Burns and Chronic, Non-Healing Wounds
62%
Policy MA07.026d
Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) Monitoring
62%
Policy MA07.009g
Routine Foot Care for Certain Medical Conditions
62%
Notification MA11.004f
Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)
62%
Policy MA09.014a
Computer Aided Detection (CAD) System for Use with Chest Radiographs
62%
Policy MA06.029
Therapeutic Drug Monitoring for Antidepressants, Antipsychotics, and Antiepileptics
62%
Policy MA06.002b
In Vitro Allergy Testing
62%
Policy MA07.039a
Magnetoencephalography (MEG) with Magnetic Source Imaging (MSI)
62%
Policy MA07.004d
Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
62%
Policy MA05.007b
Nebulizers and Inhalation Solutions
62%
Policy MA07.042
Complete Decongestive Therapy (CDT)
62%
Policy MA08.073e
Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists (e.g., ranibizumab [Lucentis®], pegaptanib sodium [Macugen®], aflibercept [Eylea®], and related biosimilars)
61%
Policy MA10.004f
Chiropractic Services
61%
Policy MA11.072
Application and Removal of Tattoos
61%
Policy MA11.095a
Lysis of Epidural Adhesions
61%
Policy MA06.032
Cobalamin (Vitamin B12), Folic Acid, and Homocysteine Testing
61%
Policy MA10.003e
Physical Medicine & Rehabilitation Services: Physical Therapy (PT) and Occupational Therapy (OT)
61%
Policy MA08.031c
Cetuximab (Erbitux®)
61%
Policy MA11.055c
Procedures for the Treatment of Gastroesophageal Reflux Disease (GERD)
61%
Policy MA00.002f
Continuous Glucose Monitors and Artificial Pancreas Device Systems (APDS)
60%
Notification MA00.005t
Experimental/Investigational Services
60%
Policy MA00.005s
Experimental/Investigational Services
60%
Policy MA11.080a
Mentoplasty or Genioplasty
60%
Policy MA10.008d
Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)
60%
Policy MA11.069b
Reduction Mammoplasty
60%
Policy MA11.025
Percutaneous Intradiscal Annuloplasty (IDET/PIRFT)
60%
Policy MA11.054b
Cataract Surgery
60%
Policy MA11.079c
Evaluation and Treatment of Erectile Dysfunction (ED)
60%
Policy MA11.031g
Spinal Cord and Dorsal Root Ganglion Stimulation
60%
Policy MA08.075c
Ramucirumab (Cyramza®)
60%
Policy MA08.085a
Asparaginase Erwinia Chrysanthemi (Erwinaze®)
60%
Policy MA09.021c
Magnetic Resonance Imaging (MRI)--Guided Focused Ultrasound Ablation
59%
Policy MA08.029b
Natalizumab (Tysabri®)
59%
Policy MA08.072e
Bevacizumab (Avastin®) and Related Biosimilars
59%
Policy MA11.058a
Otoplasty Otoplasty or Non-Surgical External Ear Molding
59%
Policy MA08.088c
Ocrelizumab (Ocrevus®)
59%
Policy MA11.106d
Treatment of Gender Dysphoria
59%
Policy MA07.055c
Allergy Immunotherapy
59%
Policy MA05.047d
Treatment of Obstructive Sleep Apnea (OSA) and Primary Snoring in Adults
58%
Policy MA06.025k
Presumptive and Definitive Drug Testing in Substance Abuse and Pain Management Treatments
58%
Notification MA08.073f
Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists and Related Biosimilars
58%
Policy MA07.031a
Laboratory-Based Vestibular Function Testing
58%
Policy MA07.056d
Photodynamic Therapy (PDT) Using Levulan® Kerastick® or Ameluz® (Aminolevulinic Acid HCl [ALA])
58%
Policy MA11.087b
Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions
58%
Policy MA07.024b
Medical and Surgical Treatment of Temporomandibular Joint Disorder
58%
Policy MA11.028e
Sacral Nerve Stimulation (SNS) and Posterior Tibial Nerve Stimulation (PTNS) for the Control of Incontinence
58%
Policy MA08.059e
Ipilimumab (Yervoy®)
57%
Policy MA06.012c
Genetic Testing for Inherited Susceptibility to Colon Cancer and Microsatellite Instability Testing (Familial Adenomatous Polyposis and Lynch Syndrome)
57%
Policy MA11.107c
Implantable Steroid-Eluting Sinus Stents
57%
Policy MA11.001i
Treatment of Varicose Veins of the Lower Extremities and Perforator Vein Incompetence
57%
Policy MA07.050f
Electromyography (EMG) Studies: Needle EMG, Surface EMG (SEMG)
57%
Policy MA07.033f
Nerve Conduction Studies (NCS) and Related Electrodiagnostic Studies
57%
Policy MA11.090
Surgical Treatment of Femoroacetabular Impingement
57%
Policy MA08.047c
Pemetrexed (Alimta®)
57%
Policy MA07.002c
Ultraviolet Light Therapy for the Treatment of Dermatological Conditions
56%
Policy MA11.044e
Artificial Intervertebral Disc Insertion
56%
Policy MA11.091b
Manipulation Under Anesthesia
56%
Policy MA08.019f
Infliximab and Related Biosimilars
56%
Policy MA11.082c
Autologous Chondrocyte Implantation (ACI)/Carticel® and Other Cell-based Treatments of Focal Articular Cartilage Lesions
56%
Policy MA06.022e
Biomarkers for Oncology
56%
Policy MA11.012c
Endovascular Grafts for Abdominal Aortic Aneurysms, Aortic-Iliac Aneurysms, and Infrarenal Aortic Aneurysms
55%
Policy MA06.010b
Genetic Testing for Inherited Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Mutations
55%
Policy Att. MA08.009h
Attachment B (MA08.009h Immune Globulin: Intravenous (IVIG), Subcutaneous (SCIG))
Dosage and Frequency Requirements
55%
Notification MA11.012d
Endovascular Grafts for Abdominal Aortic Aneurysms, Aortic-Iliac Aneurysms, and Infrarenal Aortic Aneurysms
55%
Policy MA11.105f
Aqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of Glaucoma
54%
Policy MA07.030b
Photodynamic Therapy (PDT) Using Porfimer Sodium (Photofrin®)
54%
Policy MA08.022h
Rituximab (Rituxan®) Infusion and Related Biosimilars, and Rituximab/Hyaluronidase Human for Subcutaneous Injection (Rituxan Hycela®)
54%
Policy MA06.019b
Measurement of Serum Antibodies to and Measurement of Serum Levels of Biologics
54%
Policy MA06.031c
Vitamin D Assay Testing
54%
Policy MA07.041a
Drug-Eluting Beads and Bland Embolization for the Treatment of Hepatic Malignancies









Connect with Us        


© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.